Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From DSM Nutritional Products AG

More Comfortable Than Sample Collections, Questionnaires Drive Personalized Nutrition Sales

Consumers’ saliva, blood or stool samples provide more information but questionnaires are more comfortable, says Nate Matusheski of DSM Nutritional Products business Hologram Sciences. “If you think about the user experience, there's a kind of a big difference in invasiveness across these different categories.”

Dietary Supplements Emerging Markets

DSM Remodels Nutrition Business With Fundamental Piece – Cannabinoid Ingredients

Royal DSM and Colorado’s Mile High Labs partner to provide companies in supplement, food and beverage sectors with ingredients to develop formulations with CBD and other cannabinoids. They initially are targeting the US and look to enter Canada, South America, Europe and Australia.

Cannabidiol CBD Dietary Supplements

Alibaba's Unprecedented $2.8bn Fine Could Signal Start Of Antitrust Wave In China

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

E-Commerce Enforcement

Pharma Not Immune From Coming Antitrust Wave In China

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. While the pharma sector remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions.

China Legal Issues
See All

Company Information

UsernamePublicRestriction

Register